Navigation Links
March of Dimes awards $250,000 prize to scientists who explained human sex chromosomes
Date:5/2/2011

DENVER, CO, MAY 2, 2011 Two scientists who pioneered research on the X and Y chromosomes have been chosen to receive the 2011 March of Dimes Prize in Developmental Biology.

Patricia Ann Jacobs, OBE, DSc, FRS, professor of Human Genetics, Southampton University Medical School and co-director of Research, Wessex Regional Genetics Laboratory, Salisbury, England and David C. Page, MD, director, Whitehead Institute, investigator of the Howard Hughes Medical Institute and professor of Biology at Massachusetts Institute of Technology, Cambridge, will share this year's prize.

Patricia Ann Jacobs was the first to describe a human sex chromosome abnormality with her landmark 1959 paper on Klinefelter syndrome, a disorder involving an additional X chromosome.

David Page's studies of the Y chromosome revealed its role as a complex genetic system with many specialized functions, far beyond determining male sex.

"Taken together, the research of Patricia Ann Jacobs and David Page has expanded medicine's ability to diagnose and understand the basis of infertility and many other diseases," said Michael Katz, MD, senior vice president for Research and Global Programs at the March of Dimes.

The prize was presented today to Patricia Ann Jacobs and David Page at a gala black-tie dinner and ceremony held at the Four Seasons Hotel, here. They also delivered the Sixteenth Annual March of Dimes Prize Lecture at the Colorado Convention Center at the annual meeting of the Pediatric Academic Societies. CBS sportscaster Greg Gumbel, member of the March of Dimes national Honorary Board of Trustees, hosted the award ceremony.


'/>"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.com
914-997-4286
March of Dimes Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. LGBT health research gaps and needs: IOM report release March 31
2. JCI online early table of contents: March 23, 2011
3. Fragile X researcher honored by March of Dimes
4. March/April 2011 Annals of Family Medicine tip sheet
5. JCI online early table of contents: March 14, 2011
6. Betting During March Madness May Make the Games Less Fun
7. Revitalizing Cancer Clinical Trials -- March 21 symposium
8. March of Dimes provides $2.4 million in new funding for preterm birth research
9. JCI online early table of contents: March 7, 2011
10. Dont miss March 7 pre-registration deadline for Valencia meetings
11. Journal Chest: News briefs from the March 2011 issue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be a result ... has helped many women become pregnant upon treating their diagnosis. , ... outpatient evaluations. We can provide the necessary information to diagnose and treat ...
(Date:4/26/2017)... Doylestown, Pa. (PRWEB) , ... ... ... Solutions division, which provides an agile ecosystem and domain expertise for sponsors ... end-to-end, configurable randomization and trial supply management (RTSM) software platform. Bioclinica ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... 2017 , ... Lake Park Dental is now accepting new patients with crooked ... FL. With the help of this highly-effective, yet convenient system, patients can straighten their ... and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving ... and head shops –can’t help but be heartened by the industry’s current surge. But ... aptly described as “skunk smell.” At last they can simply, safely and effectively ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: